News

Edwards, Sapien, PARTNER trial, five-year outcomes, ACC

Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible option for patients with severe aortic stenosis deemed to be at high risk for open-heart...

TAVR, TAVI, acc, ACC.15, corevalve

Key data from many transcatheter aortic valve replacement (TAVR) clinical trials will be presented as late-breakers at the American College of Cardiology (ACC) Scientific Session this weekend,...

TAVR, study, one-year outcomes, heart valve repair, JAMA, Mayo Clinic

In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement (TAVR), death rate after one year was nearly one in four, according to a study in the March...

Four-month-old Jackson Lane has a large scar that looks like a giant zipper down the center of his chest, the result of undergoing a lifesaving surgical procedure at just five days old to repair...

TMVR, Europe, heart valve repair, GlobalData

In light of a recent American Heart Association report stating that U.S. mitral valve regurgitation prevalence was 1.7 percent in 2014, a significant opportunity exists for development of an...

Pie Medical Imaging, CAAS A-Valve, qRA, angiography, heart valve repair

Pie Medical Imaging BV announced that it received 510(k) clearance from the U.S. Food and Drug Administration for its CAAS A-Valve product including the quantitative Regurgitation Analysis (qRA)...

TAVR, Henry Ford Hospital, O'Neill, Greenbaum

Transcatheter aortic valve replacement (TAVR) is not only a breakthough minimally invasive medical therapy, but offers a new business opportunity for hospitals that begin a program. The technology...

Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology:

Corevalve, valve sizes

Medtronic announced CE (Conformité Européene) mark for the 26 and 29mm sizes of the CoreValve Evolut R System, a next-generation self-expanding valve for transcatheter aortic...

Heart failure, MitraClip, International Symposium on Endovascular Therapy

A minimally invasive procedure to repair severe mitral valve regurgitation by clipping together the valve’s leaflets can improve function and quality of life and reduce the risk of hospitalization...

Clinical trial/Study, Heart Valve Repair, CoreValve System

Medtronic revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers advantages in survival and safety compared...

Neovasc Inc. has commenced a public offering in the United States of 8 million shares of the company to raise money for upcoming U.S. clinical trials and development of its transcatheter mitral...

Balloon catheters, Heart Valve repair, Cath Lab, Hybrid OR

Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of InterValve Inc.'s V8 Aortic Valvuloplasty Balloon Catheter.

Melody valve, FDA approval, PMA, pulonary valve

The U.S. Food and Drug Administration (FDA) has granted approval of Medtronic’s premarket approval application (PMA) for the Melody Transcatheter Pulmonary Valve (TPV) and its Ensemble...

FEops, TAVIguide, Series A financing, navigation, advanced visualization

FEops announced the closing of a €1.3 million (~$1.9 million USD) series A financing round, led by Capricorn Venture Partners and PMV. The funding will be used to support the launch of FEops’...

Tennessee, Knoxville, heart valve, tissue engineered, calcification proof

There could soon be new hope for those facing one of humanity's biggest health issues, thanks to research from the University of Tennessee Knoxville College of Engineering.

CT systems, CT angiography, FFR Catheters, Direct Flow Medical Transcatheter

Direct Flow Medical Inc. announced the closing of a new round of financing for the company totaling $32 million. 

Transcatheter Technologies GmbH has announced that it is expanding its product family to include Tresillo, a transcatheter mitral valve implantation (TMVI) version. 

Minneapolis Heart Institute Foundation (MHIF) researchers have performed two implants of the Lotus Cardiac Valve System as part of the REPRISE III clinical trial. 

Sorin Group, Memo 3-D ReChord, annuloplasty ring, mitral valve repair

Sorin Group announced U.S. Food and Drug Administration (FDA) clearance for Memo 3-D ReChord, a semi-rigid annuloplasty ring for mitral valve repair.